ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Is There An I’m Doing Awesome Thread?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Cataceous" data-source="post: 222813" data-attributes="member: 38109"><p>Some studies suggest problems.</p><p></p><p style="margin-left: 20px"><em>Work by Schoenfeld et al. [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946859/#R50" target="_blank">50</a>] has found that adherence to topical TRT is traditionally low and that by six months post prescription, only 37.4% of men continue on the medication. This number dropped further to 15.4% after 12 months [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946859/#R50" target="_blank">50</a>].</em></p> <p style="margin-left: 20px">[<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946859/" target="_blank">R</a>]</p><p></p><p>Of course that's just topical, and probably low-concentration as well. But in this study there's a pretty high attrition rate for injections too:</p><p></p><p style="margin-left: 20px"><strong><em>Results: </em></strong><em>The patient characteristics were similar for patients who received topical TRT or short-lasting TRT injections. Of the patients who discontinued therapy during the follow-up period, the percentages of patients who were still on therapy after 3 months were 52% and 31% for topical TRT and short-lasting TRT users, respectively. For cyclic users, there was an attrition rate of approximately 40% to 50% of patients in each cycle. For both topical TRT and short-lasting TRT injections, the gap between stopping and restarting therapy tended to decrease over time.</em></p> <p style="margin-left: 20px"></p> <p style="margin-left: 20px"><em><strong>Conclusions: </strong>In this analysis, <u>high discontinuation rates were observed</u>. The treatment pattern of TRT may be related to the disease state rather than dosing, daily use, or mode of administration.</em></p> <p style="margin-left: 20px">[<a href="https://pubmed.ncbi.nlm.nih.gov/24909541/" target="_blank">R</a>]</p></blockquote><p></p>
[QUOTE="Cataceous, post: 222813, member: 38109"] Some studies suggest problems. [INDENT][I]Work by Schoenfeld et al. [[URL='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946859/#R50']50[/URL]] has found that adherence to topical TRT is traditionally low and that by six months post prescription, only 37.4% of men continue on the medication. This number dropped further to 15.4% after 12 months [[URL='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946859/#R50']50[/URL]].[/I][/INDENT] [INDENT][[URL='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946859/']R[/URL]][/INDENT] Of course that's just topical, and probably low-concentration as well. But in this study there's a pretty high attrition rate for injections too: [INDENT][B][I]Results: [/I][/B][I]The patient characteristics were similar for patients who received topical TRT or short-lasting TRT injections. Of the patients who discontinued therapy during the follow-up period, the percentages of patients who were still on therapy after 3 months were 52% and 31% for topical TRT and short-lasting TRT users, respectively. For cyclic users, there was an attrition rate of approximately 40% to 50% of patients in each cycle. For both topical TRT and short-lasting TRT injections, the gap between stopping and restarting therapy tended to decrease over time.[/I][/INDENT] [INDENT][/INDENT] [INDENT][I][B]Conclusions: [/B]In this analysis, [U]high discontinuation rates were observed[/U]. The treatment pattern of TRT may be related to the disease state rather than dosing, daily use, or mode of administration.[/I][/INDENT] [INDENT][[URL='https://pubmed.ncbi.nlm.nih.gov/24909541/']R[/URL]][/INDENT] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Is There An I’m Doing Awesome Thread?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top